A new trading day began on Friday, with Fractyl Health Inc (NASDAQ: GUTS) stock price up 32.67% from the previous day of trading, before settling in for the closing price of $1.01. GUTS’s price has ranged from $0.82 to $3.48 over the past 52 weeks.
Annual sales at Healthcare sector company slipped by -12.32% over the past five years. Meanwhile, its annual earnings per share averaged 5.43%. With a float of $36.92 million, this company’s outstanding shares have now reached $49.92 million.
Fractyl Health Inc (GUTS) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Fractyl Health Inc is 48.86%, while institutional ownership is 17.59%. The most recent insider transaction that took place on Mar 14 ’25, was worth 22,980. In this transaction Director of this company bought 17,901 shares at a rate of $1.28, taking the stock ownership to the 17,901 shares. Before that another transaction happened on Mar 14 ’25, when Company’s Director bought 31,000 for $1.30, making the entire transaction worth $40,210. This insider now owns 31,000 shares in total.
Fractyl Health Inc (GUTS) Performance Highlights and Predictions
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.43 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.25 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 5.43% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 12.94% during the next five years compared to -12.32% drop over the previous five years of trading.
Fractyl Health Inc (NASDAQ: GUTS) Trading Performance Indicators
Here are Fractyl Health Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.22. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4837.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.05, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -1.08 in one year’s time.
Technical Analysis of Fractyl Health Inc (GUTS)
Fractyl Health Inc (NASDAQ: GUTS) saw its 5-day average volume 15.8 million, a positive change from its year-to-date volume of 0.95 million. As of the previous 9 days, the stock’s Stochastic %D was 54.15%.
During the past 100 days, Fractyl Health Inc’s (GUTS) raw stochastic average was set at 23.36%, which indicates a significant decrease from 95.45% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0741 in the past 14 days, which was lower than the 0.1345 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2194, while its 200-day Moving Average is $1.5441. Nevertheless, the first resistance level for the watch stands at $1.4467 in the near term. At $1.5533, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.7467. If the price goes on to break the first support level at $1.1467, it is likely to go to the next support level at $0.9533. Assuming the price breaks the second support level, the third support level stands at $0.8467.
Fractyl Health Inc (NASDAQ: GUTS) Key Stats
With a market capitalization of 96.74 million, the company has a total of 50,289K Shares Outstanding. Currently, annual sales are 90 K while annual income is -68,690 K. The company’s previous quarter sales were 0 K while its latest quarter income was -27,890 K.
